Literature DB >> 20596733

Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet.

Takuya Miyagi1, Tetsuo Takehara, Akio Uemura, Kumiko Nishio, Satoshi Shimizu, Takahiro Kodama, Hayato Hikita, Wei Li, Akira Sasakawa, Tomohide Tatsumi, Kazuyoshi Ohkawa, Tatsuya Kanto, Naoki Hiramatsu, Norio Hayashi.   

Abstract

BACKGROUND: Invariant natural killer T (iNKT) cells have been suggested to play critical roles in a wide range of immune responses by acting in a proinflammatory or anti-inflammatory manner. Nonalcoholic steatohepatitis (NASH) is a chronic liver disease progressing to advanced cirrhosis and hepatocellular carcinoma. Despite the abundance of iNKT cells in the liver, their role in the pathogenesis of NASH remains obscure. Here, we investigated their role in the development of diet-induced steatosis/steatohepatitis.
METHODS: We used BALB/c wild-type mice and Jα18-deficient (KO) mice lacking iNKT cells fed either a normal diet or a high-fat diet (HFD). The liver and blood were collected from these mice to examine liver inflammation, steatosis, and fibrosis at the indicated time points.
RESULTS: KO mice fed the HFD, compared with control mice fed the HFD, exhibited a clearly higher serum alanine aminotransferase level and a greater number of hepatic inflammatory foci, although there was no significant difference in hepatic lipid retention between these groups of mice. The HFD enhanced hepatic messenger RNA expression of inflammatory cytokines and chemokines in KO but not in control mice. The HFD also increased the proportion of hepatic CD4 T cells and CD8 T cells that composed hepatic inflammatory foci in KO mice, but not in the controls. Prolonged feeding with the HFD augmented liver fibrosis in KO but not in control mice.
CONCLUSIONS: These findings indicate that iNKT cells play a protective role against liver inflammation progressing to fibrosis, but not against steatosis, enhanced by dietary excess fat, suggesting a key role of these cells in NASH pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596733     DOI: 10.1007/s00535-010-0272-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  38 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 2.  Chemokines: multiple levels of leukocyte migration control.

Authors:  Bernhard Moser; Marlene Wolf; Alfred Walz; Pius Loetscher
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

3.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

4.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Mark J Soloski; Anna Mae Diehl
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

5.  The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice.

Authors:  M Ishigami; H Nishimura; Y Naiki; K Yoshioka; T Kawano; Y Tanaka; M Taniguchi; S Kakumu; Y Yoshikai
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

6.  Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.

Authors:  Yong-Han Paik; Robert F Schwabe; Ramón Bataller; Maria P Russo; Christian Jobin; David A Brenner
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

Review 7.  To be or not to be NKT: natural killer T cells in the liver.

Authors:  Mark A Exley; Margaret James Koziel
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

8.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

9.  Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.

Authors:  Yoshihiro Kamada; Hitoshi Matsumoto; Shinji Tamura; Juichi Fukushima; Shinichi Kiso; Koji Fukui; Takumi Igura; Norikazu Maeda; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa; Iichiro Shimomura; Norio Hayashi
Journal:  J Hepatol       Date:  2007-04-09       Impact factor: 25.083

10.  Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells.

Authors:  S Norris; D G Doherty; C Collins; G McEntee; O Traynor; J E Hegarty; C O'Farrelly
Journal:  Hum Immunol       Date:  1999-01       Impact factor: 2.850

View more
  21 in total

Review 1.  Fibrosis-dependent mechanisms of hepatocarcinogenesis.

Authors:  David Y Zhang; Scott L Friedman
Journal:  Hepatology       Date:  2012-06-29       Impact factor: 17.425

2.  Natural killer and natural killer T cells in liver fibrosis.

Authors:  Bin Gao; Svetlana Radaeva
Journal:  Biochim Biophys Acta       Date:  2012-09-26

Review 3.  From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

Authors:  Alexander Wree; Lori Broderick; Ali Canbay; Hal M Hoffman; Ariel E Feldstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-20       Impact factor: 46.802

Review 4.  Animal Models Correlating Immune Cells for the Development of NAFLD/NASH.

Authors:  Srikanth Iyer; Pramod Kumar Upadhyay; Subeer S Majumdar; Perumal Nagarajan
Journal:  J Clin Exp Hepatol       Date:  2015-07-09

Review 5.  Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.

Authors:  Pierluigi Ramadori; Daniela Kroy; Konrad L Streetz
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

Review 6.  Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis.

Authors:  Ki Wung Chung; Ye Eun Cho; Seung-Jin Kim; Seonghwan Hwang
Journal:  Arch Pharm Res       Date:  2022-04-07       Impact factor: 4.946

7.  Increased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury.

Authors:  Brittany V Martin-Murphy; Douglas J Kominsky; David J Orlicky; Terrence M Donohue; Cynthia Ju
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

8.  Dietary Lipids Modulate Notch Signaling and Influence Adult Intestinal Development and Metabolism in Drosophila.

Authors:  Rebecca Obniski; Matthew Sieber; Allan C Spradling
Journal:  Dev Cell       Date:  2018-09-13       Impact factor: 12.270

Review 9.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

10.  Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding.

Authors:  Brittany V Martin-Murphy; Qiang You; Hong Wang; Becky A De La Houssaye; Timothy P Reilly; Jacob E Friedman; Cynthia Ju
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.